Successful post-transition engagement can be predicted at the time of transition in type 1 diabetes

To the Editor,
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research

Related Links:

CONCLUSIONS: The mechanism underlying this phenomenon relates to a decrease in the inflammatory reaction and oxidative stress, as well as a decrease in leaky gut. Such reactions increase insulin sensitivity and reduce autoimmune responses. PMID: 32096204 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Journal of Agricultural and Food ChemistryDOI: 10.1021/acs.jafc.9b07701
Source: Journal of Agricultural and Food Chemistry - Category: Food Science Authors: Source Type: research
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - Category: Endocrinology Tags: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Source Type: research
Hi, I'm hoping I can get some direction on where to look for answers. My friend who is a type 1 diabetic had hyperbaric oxygen therapy to treat a foot wound a year ago. She completed the treatment in January 2019 and had significant decrease in her vision. She had Lasix years ago and now her vision is down to -4. Her wound doctor and eye doctor haven't been able to answer if her vision is now going to stay this way or if it will improve. Searching for articles hasn't been super helpful. They... vision loss after hyperbaric oxygen therapy
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Optometry Source Type: forums
Type 1 Diabetes (T1D) is regarded as an autoimmune disease characterized by insulin deficiency resulting from destruction of pancreatic β-cells. The incidence rates of T1D have increased worldwide. Over the past decades, progress has been made in understanding the complexity of the immune response and its role in T1D pathogenesis, however, the trigger of T1D autoimmunity remains unclear. The increasing incidence rates, immigrant studies, and twin studies suggest that environmental factors play an important role and the trigger cannot simply be explained by genetic predisposition. Several research initiatives have iden...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
Publication date: Available online 24 February 2020Source: The Lancet Diabetes &EndocrinologyAuthor(s): Amanda I Adler, Jessica Cronshaw, Carl Prescott, Sanjeev Patel, Eleanor Donegan, Jasdeep Hayre
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
DIABETES affects about four million people in the UK, which means that 1 in every 16 people will have a type of the condition. But what is the difference between Type 1 and Type 2 diabetes symptoms?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
ConclusionMetabolic biomarkers were affected by blood sample timing and underlying metabolic disease. The JECS will clarify the influences of metabolic status during pregnancy on the health and development of the offspring in future studies.
Source: Journal of Diabetes Investigation - Category: Endocrinology Authors: Tags: ORIGINAL ARTICLE Source Type: research
DiabetesMine answers key questions on the connection between type 1 diabetes and cardiovascular risk.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
Conclusions: CB-SC-derived exosomes display multiple immune modulations and primarily on monocytes, contributing to the immune education of CB-SC in the clinical treatment of autoimmune diseases.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Diabetes | Diabetes Type 1 | Endocrinology